v3.26.1
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Option Activity

The following table summarizes option activity during the six months ended June 30, 2026:

 

   Number of Options   Weighted Average
Exercise Price		   Weighted Average
Fair Value		   Weighted Average Remaining Contractual Life (Years) 
Outstanding at December 31, 2025   31,603   $68.91   $43.05    3.14 
Granted   -    -    -      
Expired   (3,915)  $78.70   $75.38      
Forfeited/Cancelled   -    -    -      
Exercised   -    -    -      
Outstanding at June 30, 2026   27,688   $67.52   $38.48    2.75 
                     
Exercisable at June 30, 2026   27,688   $67.52   $38.48    2.75 
Schedule of Outstanding Restricted Stock Units and Related Activity

The grant date fair value of RSUs granted is determined using the closing market price of the Company’s common stock on the grant date with the associated compensation expense amortized over the vesting period of the awards. The following table sets forth the outstanding RSUs and related activity for the six months ended June 30, 2026:

 

   Number of RSUs   Weighted Average Grant
Date Fair Value		 
Unvested at December 31, 2025   114,025   $34.51 
Granted   -    - 
Vested   

(29,045

)   21.36 
Forfeited/Cancelled   (3,415)   75.58 
Unvested at June 30, 2026   81,565   $37.47 
Schedule of Recognized Stock-Based Compensation Expense

The Company recognized stock-based compensation expense as follows:

 

             
   Three Months Ended June 30,   Six Months Ended June 30, 
   2026   2025   2026   2025 
Sales and marketing  $25,996   $105,342   $57,416   $241,539 
General and administrative   183,283    531,707    404,384    1,267,622 
Research and development   4,473    (56,784)   (28,934)   (53,668)
Total stock-based compensation expense  $213,752   $580,265   $432,866   $1,455,493